SCHEMBL5523402

SCHEMBL5523402

CC(=O)C1(C)CC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9577996 0.75
SCHEMBL24261137 0.75
SCHEMBL17468795 0.75
SCHEMBL3154132 0.73
SCHEMBL4398461 0.73
SCHEMBL3154125 0.73
SCHEMBL8164553 0.71 TSHR (0.39)
SCHEMBL8165588 0.71 TSHR (0.39)
SCHEMBL8164550 0.71 TSHR (0.39)
SCHEMBL5708616 0.71 TSHR (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250027072-A1 METHODS AND COMPOSITIONS RELATED TO ENGINEERED CANNABINOID RECEPTORS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2025-01-23 US disclosed
EP-4441203-A1 METHODS AND COMPOSITIONS RELATED TO ENGINEERED CANNABINOID RECEPTORS Board of Regents, The University of Texas System (US) 2024-10-09 EP disclosed
WO-2023102541-A1 METHODS AND COMPOSITIONS RELATED TO ENGINEERED CANNABINOID RECEPTORS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-06-08 WO disclosed
US-8173654-B2 Triazolopyridazine compounds JANSSEN PHARMACEUTICA N.V. (BE) 2012-05-08 US disclosed
US-8030305-B2 Triazolopyridazines as kinase modulators JANSSEN PHARMACEUTICA N.V. (BE) 2011-10-04 US disclosed
US-20090098181-A1 TRIAZOLOPYRIDAZINES AS KINASE MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-04-16 US disclosed